Vitrolife Ab · OMXSTO:VITR
Vitrolife Ab — Carnegie Healthcare Seminar 2024
8 slides from Vitrolife Ab's conference presentation, Mar 6, 2024
Slide 1: Carnegie Healthcare Seminar 2024
Carnegie Healthcare Seminar 2024 Patrik Tolf, CFO 2024-03-06
Slide 2: Mission
Mission Be the leading global partner in reproductive health, striving for better treatment outcomes for patients Global presence in Employees Sales in 2023 125 ~ 1,100 3,512 MSEK markets 2
Slide 3: Significant market opportunity in reproductive health
Significant market opportunity in reproductive health Successful treatment outcomes ~33% *** 1 in 6 134 M Access and affordability 5-7% people globally is babies born annually** estimated cycle affected by infertility* < 1% via IVF growth 3 *Source: World Health Organization **Source: United Nations
Slide 4: Corporate Strategy Vitrolife Group
Corporate Strategy Vitrolife Group Our values Integrity Market Growth Labour and Patient megatrends in demand skills shortage Consolidation Regionalisation empowerment Quality Vision with a purpose Long-term growth and profit objectives ”Enable people to fulfil the dream of having a healthy baby” An
Slide 5: Financial highlights 2023
Financial highlights 2023 Sales Organic growth* Gross margin 3,512 MSEK +5% 56.3% (3,234 MSEK) +10% in SEK In local currencies (55.0%) EBITDA Operating cash flow Earnings per share** 1,136 MSEK 757 MSEK 3.31 SEK Margin 32.3% (32.5%) (636 MSEK) (2.91 SEK) * Organic growth excluding discontinued busin
Slide 6: Sales and growth per geographical segment, 2023
Sales and growth per geographical segment, 2023 Americas EMEA APAC Total Organic growth* -4% +6% +15% +5% Sales (MSEK) 1 159 1 286 1 066 3 512 Share of total sales 33% 37% 30% * Organic growth in local currencies 6
Slide 7: Q&A
Q&A
Slide 8: Disclaimer
DISCLAIMER This presentation contains estimates and forward-looking statements, which reflect the Management’s current views with respect to the market, certain future events and financial performance. Although the statements are based upon estimates the Management believes to be reasonable, there i